LEANA HIGGINS: Open Payments
NPI 1841797305 · ZEBULON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 31 payments from 12 companies in 2025. Trend: 2023 $485 · 2024 $821 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $180 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Lilly USA, LLC | 4 | $65 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $34 |
| PFIZER INC. | 2 | $32 |
| Radius Health, Inc. | 1 | $23 |
| Averitas Pharma Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $21 |
Products named: UBRELVY, VRAYLAR, AIRSUPRA, JARDIANCE, MOUNJARO, QULIPTA, QUTENZA, Korlym.
Industry payments across NC — which companies pay providers there.
